LEXARIA BIOSCIENCE CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for the quarter ending 2024-02-29 was $517.59K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for the quarter ending 2023-11-30 was $601.66K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for the quarter ending 2020-08-31 was -$65.60K.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for the quarter ending 2020-05-31 was $1.89M.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for fiscal 2021 was $9.47M, a 259.04% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for fiscal 2020 was $2.64M, a 79.42% increase from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for fiscal 2019 was $1.47M.
- LEXARIA BIOSCIENCE CORP. stock issued during period, value, new issues for fiscal 2017 was $1.54M, a 267.70% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-02-29 | $517.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | |
| 2023-11-30 | $601.66K 10-Q · filed 2024-01-12 | |
| 2021-08-31 | $9.47M 10-K · filed 2021-11-29 | |
| 2020-08-31 | -$65.60K 10-Q · filed 2021-04-14 | $2.64M 10-K · filed 2020-10-15 |
| 2020-05-31 | $1.89M 10-Q · filed 2021-04-14 | |
| 2019-11-30 | $816.02K 10-Q · filed 2021-04-14 | |
| 2019-08-31 | $1.47M 10-K · filed 2020-10-15 | |
| 2018-11-30 | $1.47M 10-Q · filed 2020-06-29 | |
| 2017-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $1.54M 10-K · filed 2018-11-14 |
| 2016-08-31 | $271.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $419.29K 10-K · filed 2018-11-14 |
| 2015-08-31 | $512.88K 10-K · filed 2016-11-29 | |
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2014-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | |
| 2014-01-31 | $30.00K 10-Q · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |